MULLARKEY MATTHEW T 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Nov 3, 2009
Insider Transaction Report
Form 4
MULLARKEY MATTHEW T
Chief Operating Officer
Transactions
- Award
Common Stock
2009-10-30$40.04/sh+8.65$346→ 25.73 total(indirect: Non-Qualified Deferred Compensation Plan)
Holdings
- 377.453
Common Stock
- 90.904(indirect: By Savings Plan)
Common Stock
Footnotes (1)
- [F1]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.